Analysis of CML, IL-1α, and SOD showed that the CML and IL-1α were not lower in CAo + CAt on day 29 where SOD activity was higher but statistically insignificant on day 29. The gene discussed is IL1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.